Skip to content

Cellulite and Extracorporeal Shock Wave

Cellulite and Extracorporeal Shock Wave - a Randomized Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00947414
Enrollment
100
Registered
2009-07-28
Start date
2009-06-30
Completion date
2011-10-31
Last updated
2011-12-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cellulite, Microcirculation

Keywords

cellulite; shockwave; microcirculation; skin

Brief summary

Hypothesis: The combination of extracorporeal shockwave and a daily gluteal muscle strength programme is superior to the gluteal muscle strength programme alone in cellulite. Study design: Randomized-controlled trial Analysis: Intention-to-treat Outcome parameters: a) Photo, b) Nürnberger Score, c) circumference measurements, d) capillary blood flow, e) tissue oxygen saturation, f) postcapillary venous blood flow Intervention: Extracorporeal shock wave for six sessions with 2000 impulses at both gluteal and thigh regions plus a specific gluteal strength exercise training Follow-up: 12 weeks

Interventions

DEVICEExtracorporeal shockwave therapy

Extracorporeal shockwave therapy with focussed shock waves (2000 impulses, 0,25mJ/mm2) plus daily gluteal exercises

DEVICESham extracorporeal shock wave plus gluteal strength exercise

Sham extracorporeal shock wave plus gluteal strength exercise

Sponsors

Hannover Medical School
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

Females ages 18-65yrs Cellulite 1°-4° Informed consent

Exclusion criteria

Pregnancy Open wounds Females \>18yrs or \>65yrs \-

Design outcomes

Primary

MeasureTime frame
Nuernberger Score based on photo of cellulite12 weeks

Secondary

MeasureTime frame
Circumference of thigh in cm12 weeks
Capillary blood flow12 weeks
Tissue oxygen saturation12 weeks
Postcapillary venous filling pressure12 weeks

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026